Genentech Inc (NYSE:DNA) to Release Q2 2008 Earnings July 14

Genentech, Inc. (NYSE:DNA) will release the second quarter earnings for 2008 on Monday, July 14.  A live webcast with Genentech management will follow the release of the financial results at 1:45 pm PT.  To access the webcast, visit the company’s website at gene.com.

Genentech, Inc. (Genentech) is a biotechnology company that discovers, develops, manufactures and commercializes pharmaceutical products to treat patients with unmet medical needs. It commercializes multiple biotechnology products and also receives royalties from companies that are licensed to market products based on the Company’s technology.

Genentech commercializes various products in the United States, including Avastin, Rituxan, Herceptin, Lucentis, Xolair, Tarceva, Nutropin, Activase, TNKase, Cathflo Activase, Pulmozyme and Raptiva. The Company’s licensed products include Trastuzumab, Rituximab, Bevacizumab, Dornase alfa, recombinant, Alteplase and Tenecteplase, Somatropin, Daclizumab, Ranibizumab, Etanercept, Adalimumab and Infliximab.

Read more Business News on The Global Market Directory at:

http://thegmd.finditt.com/News.aspx

YourFindit is currently running a contest in which members of the business networking community site can qualify to win a $200 credit for YourFindit services. The contest winner will be announced on July 14, 2008. To qualify each member must have at least 20 members in their network and has more than 500 views on their profile

By creating a business networking profile on YourFindit visitors to your profile can view a company “About Us,” uploaded videos, posted pictures and blogs and distributed press releases. A company can also create its unique YourFindit URL and screen name that serve to increase their presence on search engines as well as post a direct link to their company Web site and network with other companies and individuals.

Join the brand-new business networking community, YourFindit and create a profile.